🔎 Trials Near Me

Akèy › Neuroblastom › New York › New York City

Etid klinik pou Neuroblastom nan New York City, NY

10 etid pou Neuroblastom ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Ap rekriteEtid obsèvasyon
  • Memorial Sloan Kettering Cancer Center, New York
Tout laj · Tout sèks · Mizajou Oct 5, 2026 · NCT00588068

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ap rekriteFaz 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Ap rekriteFaz 2Volontè an sante akeyi
  • Memorial Sloan Kettering Cancer Center, New York
Tout laj · Tout sèks · Mizajou Sep 30, 2026 · NCT04936529

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • Memorial Sloan Kettering Cancer Center ( Site 1010), New York
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Cancer Center, New York
18 Months – 19 Years · Tout sèks · Mizajou Aug 28, 2026 · NCT06528496

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Ap rekriteFaz 3
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Ap rekriteFaz 1/2
  • Memorial Sloan Kettering Kids, New York
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Tout laj · Tout sèks · Mizajou Jul 28, 2026 · NCT06057948

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Cancer Center, New York
Laj 1 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT00107289

Etid Neuroblastom nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.